Updated Jul 16, 2026
Harper Molly is a corporate insider tracked by InsiderAlpha. No SEC Form 4 filings recorded in the last 90 days. Lifetime open-market sales: $1.01M.
| Date | Ticker | Company | Code | Shares | Price | Value |
|---|---|---|---|---|---|---|
| 2025-12-16 | CPRX | CATALYST PHARMACEUTICALS, INC. | S — Open-market sale | 6.7K | $23.06 | $156K |
| 2025-12-16 | CPRX | CATALYST PHARMACEUTICALS, INC. | S — Open-market sale | 4.5K | $23.73 | $106K |
| 2025-12-16 | CPRX | CATALYST PHARMACEUTICALS, INC. | S — Open-market sale | 15.5K | $23.20 | $360K |
| 2025-12-16 | CPRX | CATALYST PHARMACEUTICALS, INC. | M — Option exercise | 20.0K | $5.78 | $116K |
| 2024-12-31 | CPRX | CATALYST PHARMACEUTICALS, INC. | M — Option exercise | 1.3K | — | |
| 2024-12-11 | CPRX | CATALYST PHARMACEUTICALS, INC. | M — Option exercise | 1.4K | — | |
| 2024-11-29 | CPRX | CATALYST PHARMACEUTICALS, INC. | S — Open-market sale | 17.5K | $22.00 | $385K |
| 2024-11-29 | CPRX | CATALYST PHARMACEUTICALS, INC. | M — Option exercise | 17.5K | $5.78 | $101K |
Harper Molly is a corporate insider — currently tracked as Director. InsiderAlpha tracks every SEC Form 4 filing in real time.
Recorded transactions: 0 open-market purchases () and 4 open-market sales ($1.01M) across all tracked filings.
All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.
Open the live Harper Molly profile on InsiderAlpha for real-time alerts, AI-scored trade ideas, and full transaction history.